We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
-11.58%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.5M
AUM Growth
-$25B
Cap. Flow
-$1.87B
Cap. Flow %
-9,134.72%
Top 10 Hldgs %
15.16%
Holding
3,274
New
1,834
Increased
671
Reduced
618
Closed
49

Top Buys

Rank Stock Value
1
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$75M
2
SBUX icon
Starbucks
SBUX
+$64.8M
3
BBY icon
Best Buy
BBY
+$59.8M
4
AME icon
Ametek
AME
+$59.7M
5
GD icon
General Dynamics
GD
+$58M

Top Sells

Rank Stock Value
1
GPC icon
Genuine Parts
GPC
+$579M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$578M
3
PAYX icon
Paychex
PAYX
+$403M
4
VMW
VMware, Inc
VMW
+$134M
5
RHT
Red Hat Inc
RHT
+$134M

Sector Composition

Rank Sector Weight
1 Technology 14.62%
2 Healthcare 13.9%
3 Financials 11.85%
4 Industrials 10.12%
5 Consumer Discretionary 8.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNT
2251
DELISTED
UNIT Corporation
UNT
$3 ﹤0.01%
+216
New +$4.67K
AKS
2252
DELISTED
AK Steel Holding Corp
AKS
$3 ﹤0.01%
+1,455
New +$5.26K
ITG
2253
DELISTED
Investment Technology Group Inc
ITG
$3 ﹤0.01%
+101
New +$2.9K
SIR
2254
DELISTED
SELECT INCOME REIT
SIR
$3 ﹤0.01%
+430
New +$3.61K
GOV
2255
DELISTED
Government Properties Income Trust
GOV
$3 ﹤0.01%
+505
New +$4.49K
REGI
2256
DELISTED
Renewable Energy Group, Inc.
REGI
$3 ﹤0.01%
+138
New +$3.73K
CBB
2257
DELISTED
Cincinnati Bell Inc.
CBB
$3 ﹤0.01%
+464
New +$5.69K
ABEO icon
2258
Abeona Therapeutics
ABEO
$342M
$2 ﹤0.01%
+12
New +$2.62K
ASTE icon
2259
Astec Industries
ASTE
$1.26B
$2 ﹤0.01%
+67
New +$2.54K
BFS
2260
Saul Centers
BFS
$883M
$2 ﹤0.01%
+44
New +$2.25K
BKE icon
2261
Buckle
BKE
$2.34B
$2 ﹤0.01%
+121
New +$2.45K
CABO icon
2262
Cable One
CABO
$250M
$2 ﹤0.01%
+3
New +$2.6K
CDXS icon
2263
Codexis
CDXS
$136M
$2 ﹤0.01%
+149
New +$2.57K
CHCO icon
2264
City Holding Co
CHCO
$2.04B
$2 ﹤0.01%
+43
New +$3.16K
CLLS
2265
Cellectis
CLLS
$283M
$2 ﹤0.01%
+150
New +$3.48K
COCP icon
2266
Cocrystal Pharma
COCP
$12.9M
$2 ﹤0.01%
+69
New +$2.27K
CTS icon
2267
CTS Corp
CTS
$1.86B
$2 ﹤0.01%
+87
New +$2.47K
CVCO icon
2268
Cavco Industries
CVCO
$4.54B
$2 ﹤0.01%
+21
New +$3.8K
CYD icon
2269
China Yuchai International
CYD
$1.74B
$2 ﹤0.01%
+167
New +$2.4K
DEA
2270
Easterly Government Properties
DEA
$1.18B
$2 ﹤0.01%
+73
New +$3.25K
DFIN icon
2271
Donnelley Financial Solutions
DFIN
$1.32B
$2 ﹤0.01%
+157
New +$2.51K
DRRX
2272
DELISTED
DURECT Corp
DRRX
$2 ﹤0.01%
+500
New +$4.36K
EHTH icon
2273
eHealth
EHTH
$43.2M
$2 ﹤0.01%
+77
New +$2.59K
ETD icon
2274
Ethan Allen Interiors
ETD
$605M
$2 ﹤0.01%
+155
New +$3.05K
FARO
2275
DELISTED
Faro Technologies
FARO
$2 ﹤0.01%
+72
New +$3.49K
89 90
91
92 93

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q4 2018 Portfolio in Review

As of Q4 2018, Glenmede Trust held 3,274 positions worth $20.5M, down 100% from $25B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Glenmede Trust withdrew a net $1.87B in Q4 2018, closing 49 positions and reducing 618 holdings. Its most notable exit was Andeavor, an estimated $48.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Glenmede Trust opened a new position in Cambrex Corporation worth $26.1K.

  • Glenmede Trust's largest Q4 2018 buy was Cambrex Corporation: 692,205 shares worth $26.1K.
  • Glenmede Trust added most to Vanguard FTSE Developed Markets ETF in Q4 2018, an estimated $75M increase.
  • Glenmede Trust's biggest Q4 2018 reduction was Genuine Parts, cutting an estimated $579M.
  • Glenmede Trust fully exited Andeavor in Q4 2018, selling an estimated $48.2M.
  • Glenmede Trust's ten largest holdings make up 15% of its $20.5M portfolio in Q4 2018.
  • Glenmede Trust opened 1,834 new positions and closed 49 in Q4 2018.
  • Glenmede Trust's portfolio value fell 100% quarter-over-quarter to $20.5M.

Based on Glenmede Trust's 13F filing for Q4 2018, filed 14 Feb 2019.